209 related articles for article (PubMed ID: 34885960)
21. Synthesis and pharmacological evaluation of novel arylpiperazine oxicams derivatives as potent analgesics without ulcerogenicity.
Szczęśniak-Sięga BM; Mogilski S; Wiglusz RJ; Janczak J; Maniewska J; Malinka W; Filipek B
Bioorg Med Chem; 2019 Apr; 27(8):1619-1628. PubMed ID: 30852078
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, COX-1/2 inhibition and antioxidant activities of new oxicam analogues designed as potential chemopreventive agents.
Szczęśniak-Sięga B; Gębczak K; Gębarowski T; Maniewska J
Acta Biochim Pol; 2018; 65(2):199-207. PubMed ID: 29906298
[TBL] [Abstract][Full Text] [Related]
23. The reactions of oxicam and sulfoanilide non steroidal anti-inflammatory drugs with hypochlorous acid: determination of the rate constants with an assay based on the competition with para-aminobenzoic acid chlorination and identification of some oxidation products.
Van Antwerpen P; Dubois J; Gelbcke M; Neve J
Free Radic Res; 2004 Mar; 38(3):251-8. PubMed ID: 15129733
[TBL] [Abstract][Full Text] [Related]
24. Forced and long-term degradation assays of tenoxicam, piroxicam and meloxicam in river water. Degradation products and adsorption to sediment.
Jiménez JJ; Muñoz BE; Sánchez MI; Pardo R
Chemosphere; 2018 Jan; 191():903-910. PubMed ID: 29145135
[TBL] [Abstract][Full Text] [Related]
25. Macrophage Inflammatory Proteins (MIPs) Contribute to Malignant Potential of Colorectal Polyps and Modulate Likelihood of Cancerization Associated with Standard Risk Factors.
Wierzbicki J; Bednarz-Misa I; Lewandowski Ł; Lipiński A; Kłopot A; Neubauer K; Krzystek-Korpacka M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338661
[TBL] [Abstract][Full Text] [Related]
26. [Cytogenetic studies of human lymphocytes under the influence of oxicams].
Kullich W; Hermann J; Klein G
Z Rheumatol; 1990; 49(2):77-81. PubMed ID: 2349840
[TBL] [Abstract][Full Text] [Related]
27. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers.
Patoia L; Santucci L; Furno P; Dionisi MS; Dell'Orso S; Romagnoli M; Sattarinia A; Marini MG
Br J Rheumatol; 1996 Apr; 35 Suppl 1():61-7. PubMed ID: 8630640
[TBL] [Abstract][Full Text] [Related]
28. Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report.
Trujillo MJ; de Barrio M; Rodríguez A; Moreno-Zazo M; Sánchez I; Pelta R; Tornero P; Herrero T
Allergol Immunopathol (Madr); 2001; 29(4):133-6. PubMed ID: 11674927
[TBL] [Abstract][Full Text] [Related]
29. Membrane fusion: a new function of non steroidal anti-inflammatory drugs.
Chakraborty H; Mondal S; Sarkar M
Biophys Chem; 2008 Sep; 137(1):28-34. PubMed ID: 18617319
[TBL] [Abstract][Full Text] [Related]
30. Comparative biochemical pharmacology of the oxicams.
Fenner H
Scand J Rheumatol Suppl; 1987; 65():97-101. PubMed ID: 3500509
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents.
Szczęśniak-Sięga BM; Wiatrak B; Czyżnikowska Ż; Janczak J; Wiglusz RJ; Maniewska J
Bioorg Chem; 2021 Jan; 106():104476. PubMed ID: 33250206
[TBL] [Abstract][Full Text] [Related]
32. Blockade of neurokinin-1 receptor attenuates CC and CXC chemokine production in experimental acute pancreatitis and associated lung injury.
Sun J; Bhatia M
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G143-53. PubMed ID: 16873893
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
Chakraborty H; Banerjee R; Sarkar M
Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
[TBL] [Abstract][Full Text] [Related]
35. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
[TBL] [Abstract][Full Text] [Related]
36. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.
Engelhardt G; Homma D; Schlegel K; Utzmann R; Schnitzler C
Inflamm Res; 1995 Oct; 44(10):423-33. PubMed ID: 8564518
[TBL] [Abstract][Full Text] [Related]
38. Meloxicam.
Khalil NY; Aldosari KF
Profiles Drug Subst Excip Relat Methodol; 2020; 45():159-197. PubMed ID: 32164967
[TBL] [Abstract][Full Text] [Related]
39. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
Chakraborty H; Roy S; Sarkar M
Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.
Smiley ST; King JA; Hancock WW
J Immunol; 2001 Sep; 167(5):2887-94. PubMed ID: 11509636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
